Detalles de la búsqueda
1.
Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish.
Cell;
177(7): 1903-1914.e14, 2019 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31031007
2.
Atypical cystic hypersecretory lesions of the breast commonly harbour TP53 alterations.
Histopathology;
83(6): 989-993, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37771083
3.
Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study.
Breast Cancer Res;
24(1): 90, 2022 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36527133
4.
Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score.
Breast Cancer Res Treat;
173(2): 375-383, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30350269
5.
Sequence analysis of mutations and translocations across breast cancer subtypes.
Nature;
486(7403): 405-9, 2012 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22722202
6.
Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
Cancer;
123(17): 3261-3268, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28485815
7.
Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study.
Breast Cancer Res;
18(1): 1, 2016 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26728744
8.
Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14.
Breast Cancer Res Treat;
157(1): 101-8, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27116182
9.
Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification.
Mol Cell;
31(2): 294-301, 2008 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-18657511
10.
The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway.
Proc Natl Acad Sci U S A;
109(8): 2736-41, 2012 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-21690342
11.
A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity.
Breast Cancer Res;
16(2): R25, 2014 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24625110
12.
VAV3 mediates resistance to breast cancer endocrine therapy.
Breast Cancer Res;
16(3): R53, 2014 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-24886537
13.
CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 12-2016. An 8-Year-Old Boy with an Enlarging Mass in the Right Breast.
N Engl J Med;
374(16): 1565-74, 2016 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27096583
14.
Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS).
Breast Cancer Res Treat;
143(2): 343-50, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24346130
15.
Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer.
Breast Cancer Res Treat;
145(1): 61-71, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24715381
16.
Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
BMC Cancer;
14: 884, 2014 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-25427824
17.
Integrated proteomic, transcriptomic, and biological network analysis of breast carcinoma reveals molecular features of tumorigenesis and clinical relapse.
Mol Cell Proteomics;
11(6): M111.014910, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22240506
18.
Predisposition to cancer caused by genetic and functional defects of mammalian Atad5.
PLoS Genet;
7(8): e1002245, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21901109
19.
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.
Lancet Oncol;
14(11): 1067-1076, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24035531
20.
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial.
Clin Cancer Res;
30(9): 1984-1991, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38376912